BW 2258U89
Alternative Names: 2258U89; BW 10; BW2258U89Latest Information Update: 02 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antidepressants; Antineoplastics; Appetite stimulants; Oligopeptides
- Mechanism of Action Bombesin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Eating disorders
Most Recent Events
- 08 Jul 1998 No-Development-Reported for Cancer in United Kingdom (Unknown route)
- 08 Jul 1998 No-Development-Reported for Eating disorders in United Kingdom (Unknown route)
- 10 Nov 1995 Preclinical development for Cancer in United Kingdom (Unknown route)